Abstract
The complications associated with heart disease inevitably progress toward heart failure. This occurs either when the heart fails to pump blood at a rate required or when the heart can do so only with an elevated filling pressure. It has been estimated that two million individuals in the United States are currently undergoing treatment for heart failure, and that 400,000 new cases occur annually. According to a recent American Heart Association report, about 1.5 million Americans suffer acute myocardial infarction (AMI) each year (1). Among the two thirds who survive an event of myocardial infarction, two thirds do not make a full recovery. The single most significant disease in terms of both mortality and morbidity, AMI accounts for one half of the nearly one million deaths each year by cardiovascular disease in patients who have had noncardiac surgery. In the United States, the economic burden of coronary artery disease (CAD) is estimated at $50 to 100 billion per year in medical interventions and lost wages (10,21).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
American Heart Association. Heart and Stroke Facts: 1996 Statistical Supplement Dallas: American Heart Association; 1996:1–23.
Adams JE III, Abendschein DR, Jaffe AS. Biochemical markers of myocardial injury: Is MB creatine kinase the choice for the 1990s? Circulation. 1993;88:750.
Apple FS. Glycogen phosphorylase BB and other cardiac proteins: Challenges to creatine kinase MB as the marker for detecting myocardial injury. Clin Chem. 1995;41:966–978.
Bluestein BI, Walczak IM, Chen S. Fiber optic evanescent wave immunosensor for medical diagnostics. TIBTECH. 1990;8:161.
Bodor GS, Porterfield D, Voss EN, Smith S, Apple FS. Cardiac troponin-I is not expressed in fetal and healthy or diseased adult human skeletal muscle tissue. Clin Chem. 1995;41:1710.
Braunwald E. Control of myocardial oxygen consumption: Physiologic and clinical considerations. Am J Cardiol 1971;27:416.
Braunwald E. ed. Heart Disease: A Textbook of Cardiovascular Medicine. 5th edition. WB Saunder; 1997.
Buda AJ, Zotz RJ, Pace DP, Krause LC. Comparison of two-dimensional echocardiographic wall motion and wall thickening abnormalities in relation to the myocardium at risk. Am Heart J. 1986;111:587.
Cummins P, Young A, Auckland ML, Michie CA, Stone PCW, Shepstone BJ. Comparison of serum cardiac specific troponin-I with creatine kinase, creatine kinase-MB isoenzyme, tropomysin, myoglobin, and C-reactive protein release in marathon runners: Cardiac or skeletal muscle trauma? Ear J Clin Invest. 1987;17:317.
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA. 1993;269:3015.
Feigenbaum H. Echocardiography. In: Braunwald E, ed. Heart Disease. A Textbook of Cardiovascular Medicine. 5th edition. WB Saunders; 1997.
Fisch C. Evolution of the clinical electrocardiogram. J Am Coll Cardiol. 1989;14:1127.
Johnson CL, Rifkind BM, Sempos CT, Carroll MD, Bachorik PS, Briefel RR, Gordon DJ, Burt VZ, Brown CD, Lippel K, Cleeman J. Declining serum total cholesterol levesl among US adults: The National Health and Nutrition Examination Surveys. JAMA. 1993;269:3002.
Johnson JR, DiPalma JR. Intramyocardial pressure and its relation to aortic blood pressure. Am J Physiol 1939;125:234.
Juronen EI, Viikmaa MH, Mikelsaar AN. Rapid simple and sensitive antigen capture ELISA for the quantitation of myoglobin using monoclonal antibodies. J Immunol Methods. 1988;111:109.
Konings CH, Funke Kupper AJ, Verbeugt FWA. Comparison of two latex agglutination test kits for serum myoglobin in the exclusion of acute myocardial infarction. Ann Clin Biochem. 1989;26:254.
Kresh JY, Brockman SK, Cobanoglu MA, Goldman SM. Continuous intraoperative monitoring of myocardial tissue pressure: Experimental and clinical results. Surg Forum. 1985;36:301.
Kricka LJ. Selected strategies for improving sensitivity and reliability of immu-noassays. Clin Chem. 1994;40:347.
Lowe CR. An introduction to the concepts and technology of biosensors. Biosensors. 1985;1:3.
Ligler FS, Rabbany SY. Biological microstructures in biosensors. In: Schnur JM, Peckerar M, eds. Synthetic Microstructures in Biological Research. New York: Plenum, 67, 1992.
National Cholesterol Education Program. Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). Circulation. 1994;89:1329.
Mair J, Wagner I, Morass B, Fridrich L, Lechleitner P, Dienstl F, Calzolari C, Larue C, Puschendorf B. Cardiac troponin I release correlates with myocardial infarction size. Eur J Clin Chem Clin Biochem. 1995;33:869.
Murphy DA, Armour JA. Human cardiac nerve stimulation. Ann Thorac Surg. 1992;54:502.
Porter WT. The influence of the heart-beat on the flow of blood through the walls of the heart. Am J Physiol. 1898;1:145.
Rabbany SY. The Genesis of Intramyocardial Pressure. Philadelphia: University of Pennsylvania. Available from Ann Arbor J MI: University Microfilms; 1991. Dissertation.
Rabbany SY, Donner BL, Ligler FS. Optical immunosensors. Crit Rev Biomed Eng. 1994;22:307.
Rabbany SY, Kresh JY, Noordergraaf A. Intramyocardial prssure: Interaction of myocardial fluid pressure and fiber stress. Am J Physiol. 1989;257:H357.
Rabbany SY, Kusterbeck AW, Bredehorst R, Ligler FS. Effect of antibody density on the displacement kinetics of flow immunoassay. J Immunol Methods. 1994;168:227.
Rabban SY, Kusterbeck AW, Bredhorst R, Ligler FS. Binding kinetics of immobilized antibodies in a flow immunosensor. Sensors Actuators. 1995;29:72.
Roberts R. Enzymatic estimation of infarct size: Thrombolysis induced its demise. Will it now rekindle its renaissance? Circulation. 1990;81:707.
Scaramucci GB. Diario Parmeuse. 1689. Cited by Von Haller, A: Element a Physiologiae Corporis Humani. Lausanne, Switzerland. Sumptibus Marci-Michael, Bousquet et sociorum 1778;4:459.
Thompson RJ, Jackson AP, Langolis N. Circulating antibodies to mouse monoclonal immunoglobulins in normal subjects: Incidence, species specificity, and effects of a two-site assay for creatine kinase-MB isoenzyme. Clin Chem. 1986;32:476.
Tsung JS, Tsung SS. Creatine kinase isoenzymes in extracts of various human skeletal muscles. Clin Chem. 1986;32:1568.
Vaidya HC, Beatty BG. Eliminating interference from heterophilic antibodies in a two-site immunoassay for creatine kinase MB by using F(ab’)2 conjugate and polyclonal mouse IgG. Clin Chem. 1992;38:1737.
Wilkinson JM, Grand RJA. Comparison of amino acid sequence of troponin I from different striated muscle. Nature. 1978;271:31.
Zaninotto M, Altinier S, Lachin M, Carraro P, Mario P. Fluoroenzymometric method to measure cardiac troponin I in sera of patients with myocardial infarction. Clin Chem. 1996;42:1460.
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Rabbany, S.Y. (1998). New-Age Rapid Diagnosis of Acute Myocardial Injury. In: Analysis and Assessment of Cardiovascular Function. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-1744-2_8
Download citation
DOI: https://doi.org/10.1007/978-1-4612-1744-2_8
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-7261-8
Online ISBN: 978-1-4612-1744-2
eBook Packages: Springer Book Archive